Concepedia

R. M. Connolly

RM

Statistics

Publications

2

Citations

23

H-Index

2

Active since

2010

R. M. Connolly is an author specializing in oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

2010–2011

2

Publications

2

A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC).

R. M. Connolly, Michelle A. Rudek, Howard L. Mc Leod et al. · Journal of Clinical Oncology · 2011 · 13 citations

, , +23

A multi-institutional double-blind phase II study evaluating response and surrogate biomarkers to carboplatin and nab-paclitaxel (CP) with or without vorinostat as preoperative systemic therapy (PST) in HER2-negative primary operable breast cancer (TBCRC008).

R. M. Connolly, Stacie C. Jeter, Jane Zorzi et al. · Journal of Clinical Oncology · 2010 · 10 citations

, , +11

1–2 of 2